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Freeze-drying a biodegradable polymer, poly(L-lactic acid) (PLLA), from 1,4-dioxane solutions provided very porous spherical
particles of ca. 3mm in radius with speciﬁc surface area of 8–13m2 g−1. The surface of the particle was found to be less porous
compared with its interior. To apply the freeze-dried PLLA (FDPLLA) to drug delivery system, its morphology and drug releasing
kinetics were investigated, bovine serum albumin (BSA) being used as a model drug compound. Immersion of FDPLLA into a
BSA aqueous solution gave BSA-loaded FDPLLA, where mass fraction of the adsorbed BSA reached up to 79%. Time-dependent
release proﬁle of BSA in water suggested a two-step mechanism: (1) very rapid release of BSA deposited on and near the particle
surface, which results in an initial burst, and (2) leaching of BSA from the interior of the particle by the diﬀusion process. It was
suggested that the latter process is largely governed by the surface porosity. The porosity of both the interior and surface was found
to decrease remarkably as the concentration of the original PLLA/1,4-dioxane solution increases, C0.T h u s ,C0 is a key parameter
that controls the loading and releasing of BSA.
1.Introduction
In recent decades, controlled drug release from capsules
made from biodegradable and biocompatible polymers
has been extensively studied. Polymer microspheres with
dispersed medication are often used for this purpose [1]. In
general, the drug release from microspheres are considered
to occur both by degradation of the polymer matrix and
by simple diﬀusion of the drug molecules. It has been
revealedthat various factorsaﬀectthe featureofdrug release,
such as the size and structure of the microsphere, porosity,
chemistry, degradability, and molar mass of the polymer
material,andpHvalueofthemedium[1].Furthermore,pH-
sensitive release technique has been developed [2–4].
Microspheres for the drug release have been prepared by
polymerization method or by solvent removing method [1].
Vinyl polymer microcapsules can be prepared by emulsion,
suspension, or dispersion polymerization [1, 5]. Further-
more, controlled/living radical polymerization, which has
been developed recently, can provide microspheres with
well-controlled morphology [6]. On the other hand, for
biodegradable polymers such as poly(L-lactic acid) (PLLA),
poly(glycolic acid) (PGA), and various naturally occurring
polymers, microspheres are usually prepared by solvent
evaporation or spray-drying method [7–17].
It needs to be noted that porous biodegradable polymer
particles can also be prepared by freeze-drying technique
[18], and by solution crystallization method [19]. We have
prepared porous PLLA particles by the freeze-drying method
from 1,4-dioxane solutions and have investigated their
structure and thermal properties precisely [18, 20]. It has
been demonstrated that the interior of the freeze-dried PLLA
(FDPLLA) is very porous consisting of thin membranes
forming a ﬁne, randomly arrayed tissue. In addition, crys-
tallizability of FDPLLA is remarkably high due to the mobile
surface layer of the ﬁne membranes, and thus, the range of
crystallinitythatcanbeachievedisexpandedfromthatofthe
bulk PLLA. The FDPLLA seems to be suitable for a carrier
in controlled drug delivery system because of its high void
content and biocompatibility. The porosity of the FDPLLA is
expected to be controlled by freeze-drying conditions. Addi-
tionally, it seems that the shape and size of the freeze-dried
material can be controlled by the method of freezing. For
example, if the solution is frozen as droplets, sphere-shaped2 ISRN Pharmaceutics
material is yielded, and if it is frozen in a space between two
ﬂat substrates with a spacer, a plate-like one is yielded.
In this paper, we investigate the possibility of applying
the porous FDPLLA to controlled drug release system. We
prepare protein-loaded FDPLLA particles with radius of
ca. 3mm and examine their morphology. We here employ
a protein, bovine serum albumin (BSA) as a model drug
compound. BSA can be loaded into the FDPLLA particle by
simply immersing them into a BSA aqueous solution and
subsequentdrying.ThereleasekineticsofBSAfromtheBSA-
loaded FDPLLA in water is investigated, and the results are
discussed in conjunction with the morphology.
2. ExperimentalMethods
2.1. Preparation and Characterization of FDPLLA. PLLA
with a molar mass of 210kDa containing 98% L units
was supplied from Mitsui Chemicals Co. 1,4-Dioxane was
purchased from Nacalai Tesque, which was distilled before
use. PLLA/1,4-dioxane solutions of which the PLLA concen-
tration of C0 = 2.0, 5.0, and 8.0wt% were prepared. The
solution was directly poured into liquid N2 (77K) drop by
drop so as to the solution was rapidly frozen. The frozen
droplets were dried under vacuum for 168h to remove
the frozen solvent by sublimation, which yielded FDPLLA
spherical particles with high porosity. The diameter of the
particle was approximately 3mm, being almost independent
of C0. More detailed procedure of freeze-drying is described
elsewhere [18, 20]. Gravimetric measurement after heating
at 190◦C revealed that the residual solvent contained in
the FDPLLA was estimated to be less than 0.1wt%. We
conﬁrmed by diﬀerential scanning calorimetry (DSC) and
wide-angle X-ray scattering (WAXS) that the as-prepared
FDPLLA is completely amorphous as we reported elsewhere
[20]. Additionally, we also prepared crystallized FDPLLA by
annealing as-prepared FDPLLA at 115◦C for 15min. The
crystallinity of the crystallized samples was evaluated from
the net heat of endotherm detected during a heating scan
of DSC at 10Kmin−1. Speciﬁc surface area of the obtained
FDPLLA, σ, was evaluated by the Brunauer-Emmett-Teller
(BET) adsorption isotherm of krypton. Volume fraction of
void in the particle, rv, was also evaluated by measuring
the mass and apparent size of the particle. Literature value
1.248gcm−3 for the density of amorphous PLLA was used
in this evaluation [21]. Scanning electron microscopy (SEM)
was performed to investigate the morphology of FDPLLA
particles by using a Hitachi S-2600H electron microscope.
2.2. Loading and Releasing of BSA. BSA (66,776Da,
lyophilized powder, >96%) was purchased from Sigma-
Aldrich. FDPLLA was immersed in an aqueous solution
of BSA (20wt%) in the following procedure. FDPLLA
particles were placed in a sandwich cell that was made of
two glass plates and a rubber spacer and were degassed
under vacuum together with a BSA solution in a vacuum
chamber (see Figure 1). Then, the open side of the cell
was immersed in the BSA solution, followed by releasing
the air into the chamber to atmospheric pressure. This
method allows the solution to permeate thoroughly into
the interior of the FDPLLA particle. On the contrary, when
FDPLLA particle was simply added to the BSA solution, the
solution hardly permeated into FDPLLA because of very
high hydrophobicity of PLLA. After 10min, the FDPLLA
immersed in the solution was then separated and dried
at room temperature in atmosphere for 24h, followed by
drying under vacuum for 24h. The mass of BSA loaded in
FDPLLA was evaluated by gravimetric measurement.
In the release experiments, the ratio of BSA-loaded
FDPLLA/water was determined so as to the expected ﬁnal
absorbance of BSA at 279nm is in the rage 0.5–0.6.
In a typical experiment, 50mg of BSA-loaded FDPLLA
with C0 = 2.0wt% was immersed in 40mL of distilled
water. The mixture was subject to constant stirring, the
temperature being controlled at 37.0 ± 0.1◦C. The amount
of released BSA was measured by monitoring ultraviolet
(UV) absorption at 279nm, where a peak characteristic
of BSA is located with a molar absorption coeﬃcient of
43,824M−1 cm−1.TheUVmeasurementsweredonebyusing
aUVspectrometerHitachiU-3900H.Fromtheresults,time-
dependent proﬁle of the BSA concentration of the aqueous
phase was evaluated.
3. Results and Discussion
3.1. Morphology. The yielded FDPLLA particles were
revealed to be very porous. Table 1 shows speciﬁc surface
area σ a n dv o i df r a c t i o nrv (volume fraction of void) of
FDPLLA particles. The void content was evaluated from
averaged values of apparent radius and mass of the particle.
It is noted from Table 1 that for amorphous FDPLLA, C0 +
rv approximately equals 100%. This means that the shape
of the as-freeze-dried sphere is originated from the solution
droplet: the frozen droplets undergo no shrinkage upon
freeze drying. Figure 2 shows scanning electron micrographs
for FDPLLA particles. We see that the porosity is greater for
lower C0. The thickness of the thin membranes that form
ﬁne tissue in the interior was estimated to be 100–200nm
from electron microscopy, which coincides with the results
of speciﬁc surface area: thickness of a hypothetical ﬂat ﬁlm
df that has the same speciﬁc surface area was estimated as
df = 2/(ρσ), where ρ is the density of amorphous PLLA, and
it ranged from 120 to 191nm (see Table 1).
Figure 2 also shows that the surface of the sphere is
less porous than that in the interior. Fine tissue that is
typically seen in the interior appears to have melted on the
surface, which results in reduction of surface porosity. This is
typically observed in Figures 2(c) and 2(e). It appears that
a less porous skin is formed on the surface. By analyzing
the SEM images, we estimated surface porosity as void
fraction of the surface, Avoid/At,w h e r eAvoid is the area of
the voids (pores) on the surface, and At is the total area of
the surface. The results are presented in Table 2. The surface
porosity decreases with increasing C0, and it is extremely low
for C0 = 8.0wt%. The formation of the surface skin layer
may have occurred during freezing. When a droplet of the
solution is quenched in liquid N2, solid-liquid microphaseISRN Pharmaceutics 3
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Figure 1: Immersion of FDPLLA particles in BSA aqueous solution by using a cell made of glass plates and a rubber spacer.
Table 1: Averaged radius a, speciﬁc surface area σ, and void content rv of FDPLLA particle.
C0 (wt%) a (mm) σ (m2 g−1) df (nm)a rv (vol%)
2.0 Amorphous 1.47 ± 0.03 13.4 120 98.1
2.0 Crystallized (0.8) 87.5
5.0 Amorphous 1.58 ± 0.07 11.9 135 94.4
5.0 Crystallized (1.1) 85.0
8.0 Amorphous 1.49 ± 0.11 8.4 191 92.3
8.0 Crystallized (1.1) 80.2
aHypothetical membrane thickness estimated as df = 2/(ρσ).
Table 2: Void fraction on the surface, Avoid/At of FDPLLA particle.
C0 (wt%) Avoid/At(%)
2.0 Amorphous 67.3
5.0 Amorphous 10.7
8.0 Amorphous 3.0
separation would occur ﬁrst, that is, crystallized solvent
(solid phase) and unfrozen solution (liquid phase) may be
formed. As the freezing process proceeds, the liquid phase
becomesconcentratedandﬁnallyitvitriﬁeswhenmostofthe
solvent has moved to the frozen phase. Although the whole
frozen process occurs within a few seconds in liquid N2, the
intermediate liquid phase may have enough time to relax by
reducing its interfacial area, which leads to surface melting.
This process may occur preferentially on the surface where
free space for the relaxation is available.
The mass fraction of BSA loaded in the FDPLLA is
presented in Table 3,w h i c hi sd e ﬁ n e da sfBSA = mBSA /mt,
where mBSA is the mass of BSA adsorbed in FDPLLA,
and mt is the total mass of BSA-loaded FDPLLA. The
obtained values of fBSA are extremely large compared with
the PLLA scaﬀold prepared by the phase separation method
[22]. This feature is originated from the high porosity of
the present FDPLLA, which seems to be suitable for drug
delivery applications. Figure 3 shows morphology of the
BSA-loaded FDPLLAs. The interior of the particle exhibits a
similarfeatureofporousmorphologytothatoftheunloaded
FDPLLA. The loaded BSA in the interior of the particle
exists as agglomerates, which is typically seen in Figure 3(b).
The high porosity for the BSA-loaded FDPLLA is reasonably
understood from their void fraction rv,l o a d e d presented in
Table 3: it is rather high even after the BSA adsorption,
indicating that the BSA-loaded FDPLLA is still very porous.
Here, rv,loaded was estimated from fBSA as
rv,loaded = 1 − (1 −rv)
 
1+
fBSA
1 − fBSA
ρPLLA
ρBSA
 
,( 1 )
where rv is the void fraction before the BSA loading, and
ρPLLA and ρBSA (1.07gcm−3) are the densities of PLLA and
BSA, respectively. On the other hand, the surface of the
particle seems to be covered with deposited BSA, and the
voids on the surface is hidden for C0 = 5.0 and 8.0wt%.
From electron micrographs, the deposited BSA layer on the
surface for C0 = 5.0 and 8.0wt% was roughly estimated to
be as thin as 0.5–1μm, which does not alter the apparent size
of the particle signiﬁcantly. As for C0 = 2.0wt%, the surface
is still ragged, which may be originated from the very porous
surface shown in Figure 2(a).
We found that the apparent size of FDPLLA particles is
reduced upon isothermal crystallization at 115◦C for 15min.
This tendency was remarkable for C0 = 2.0wt%. Addi-
tionally, the spherical shape was deformed into indeﬁnite
shape. The apparent averaged radius is presented in Table 1
in the parentheses. This is just a rough estimation, because
the particles were not spherical. Table 1 also shows rv values
estimated from this averaged radius. Figure 4 shows a typical
morphology of the interior of crystallized FDPLLA (C0 =
8.0wt%). Aggregation of curved ﬁne layers is observed; each
layer is probably made of stacked crystalline lamellae of
PLLA. The crystallinity of these samples was revealed to be
in the range 0.14–0.16. The space (void) between them was
found to be reduced upon crystallization, which is consistent
with the reduction of the apparent size of the particle (see4 ISRN Pharmaceutics
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Figure 2: Electron microscopic images of the surface and interior of as-prepared FDPLLA particles. (a) C0 = 2 . 0w t % ,s u r f a c e ,( b )C0 =
2.0wt%, interior, (c) C0 = 5.0wt%, surface, (d) C0 = 5.0wt%, interior, (e) C0 = 8.0wt%, surface, and (f) C0 = 8.0wt%, interior.ISRN Pharmaceutics 5
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Figure 3: Electron microscopic images of the surface and interior of BSA-loaded FDPLLA particles. (a) C0 = 2.0wt%, surface, (b) C0 =
2.0wt%, interior, (c) C0 = 5.0wt%, surface, (d) C0 = 5.0wt%, interior, (e) C0 = 8.0wt%, surface, and (f) C0 = 8.0wt%, interior.6 ISRN Pharmaceutics
10µm
Figure 4: Electron microscopic image of the interior of crystallized
FDPLLA particle with C0 = 8.0wt%.
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Figure 5: BSA release [BSA]t/[BSA]∞ at 37◦C plotted against
elapsed time. The solid curves indicate the results of the nonlinear
least squares ﬁtting analysis.
Table 1). As for the BSA loading, fBSA is smaller than that for
the corresponding amorphous FDPLLA as shown in Table 3.
It is most likely that this is due to the reduction of void
fraction upon crystallization.
3.2. Release Kinetics. As the crystallized FDPLLA particles
have indeﬁnite shape which seems to prevent simple kinetic
analysis, we here report the release data only from the amor-
phousFDPLLA.TheamountofBSAreleasedintowaterfrom
the FDPLLA was evaluated by UV absorbance at 279nm.
Figure 5 shows release of BSA with respect to elapsed time
as presented by [BSA]t/[BSA]∞, where [BSA]t is the BSA
concentrationinwaterattimet,and[BSA] ∞ istheﬁnalvalue
of the BSA concentration that was estimated from the total
mass of BSA loaded in the FDPLLA. It is clearly seen that the
release rate increases as C0 decreases. For the three samples, a
major portion of BSA release occurs within at least several
hours, which suggests that the release occurs mainly by
Table 3:MassfractionofBSA fBSA andvoidfractionrv,loaded ofBSA-
loaded FDPLLA.
C0 (wt%) fBSA (wt%) rv,loaded (vol%)
2.0 Amorphous 79.1 89.7
2.0 Crystallized 53.0 71.1
5.0 Amorphous 63.4 83.1
5.0 Crystallized 43.8 71.4
8.0 Amorphous 51.3 82.8
8.0 Crystallized 34.5 68.0
the diﬀusion mechanism prior to the degradation of PLLA:
we conﬁrmed that signiﬁcant hydrolysis of PLLA in water
under the present condition takes more than several days.
We infer that the C0 dependence of release rate may
be due to the diﬀerence in surface porosity. Additionally,
it is seen that a burst of release occurs in the early
period, which is probably due to rapid solvation of BSA
deposited on the surface of the particles as observed in
Figures 3(a), 3(c),a n d3(e). We speculate that the release
of BSA from the interior of the particle occurs in two
subsequent processes: permeation of water into the FDPLLA
sphere, and the diﬀusion of BSA out of the particle. Both
of these processes are aﬀected signiﬁcantly by the surface
porosity. The values of Avoid/At in Table 2 indicate that the
surface porosity decreases remarkably with increasing C0.
The interior porosity of the particle also decreases with
increasing C0 as shown in Table 1, but this dependence is
weaker than that of the surface porosity. Thus, it is likely that
the release rate due to the diﬀusion process from the interior
is largely governed by the surface porosity.
TheproﬁlesinFigure 5suggestthatthereleasetakesplace
in two steps: dissolution of the BSA deposited on or near the
surface occurs ﬁrst, which is responsible for the initial burst,
and then, BSA leaches out from the interior of the particle.
The ﬁrst step occurs within a few minutes, as evidenced by
nonzero values of [BSA]t/[BSA]∞,a t6 0si nFigure 5 (0.1–
0.3). The release of the second step commences after certain
induction period, which is needed for water to permeate into
the interior of the particle, and this depends strongly on the
surface porosity as discussed above. The release rate due to
the second step is governed by the diﬀusion process of BSA
intheparticleandthroughthesurfaceskinwithlessporosity.
To analyze the time-evolution proﬁles in Figure 5,w e
assume a model of Fickian diﬀusion from a nonswellable
sphere [23]. In this case, an analytical expression for
[BSA]t/[BSA]∞ is given by
[BSA]t
[BSA]∞
= 1 −
6
π2
∞  
n=1
1
n2 exp
 
−
Dn2π2t
a2
 
,( 2 )
where D is the diﬀusion coeﬃcient of BSA travelling in
the FDPLLA particle, and a is the radius of the FDPLLA
sphere. We further takes into account the initial burst as
a baseline fraction parameter b, and the induction periodISRN Pharmaceutics 7
Table 4: Parameters obtained from the analysis of [BSA]t/[BSA]∞
versus time.
C0 (wt%) b ti(s) D (m2 s−1)
2.0 0.32 2.0 × 102 2.1 × 10−10
5.0 0.15 7.5 × 102 6.0 × 10−11
8.0 0.13 6.7 × 103 1.7 × 10−11
for the second step as ti, thus, the time-dependent release is
expressed by
[BSA]t
[BSA]∞
= (1 −b)
⎧
⎨
⎩1 −
6
π2
∞  
n=1
1
n2 exp
 
−
Dn2π2(t −ti)
a2
  ⎫
⎬
⎭ +b.
(3)
The experimental proﬁles were ﬁtted with equation (3)b y
nonlinear least squares ﬁtting, D and ti being treated as
variableparameters,andtheobtainedbestﬁtvaluesarelisted
in Table 4. In the analysis, the series in equation (3)w a s
cut oﬀ at n = 400; we conﬁrmed that this does not aﬀect
the results signiﬁcantly. Equation (3) assumes that both the
distribution and diﬀusion rate of BSA are spatially uniform
in the spherical particle, thus the evaluated D is regarded
as an averaged diﬀusion coeﬃcient over the interior of the
sphere including the surface skin layer.
The diﬀusion coeﬃcient D for C0 = 2.0wt% is more
than an order of magnitude greater than that for C0 =
8.0wt%. This can be understood by the large diﬀerence
in the surface porosity between the two samples (Table 2).
Thus, it is reasonable to consider that the release rate due
to the diﬀusion process is largely aﬀected by the porosity
of the surface skin layer. The baseline parameter b decreases
with increasing C0, which implies that the release due to the
initial burst is larger for lower C0. This suggests that the
initial burst is originated not only from the BSA portion
deposited on the surface but also from that deposited near
the surface. The amount of the latter portion may be greater
for higher surface porosity. The induction time ti increases
with increasing C0. We infer that during the induction
period, water goes into the particle, and this process is
considered to be aﬀected strongly by the surface porosity.
4. Conclusions
In this study, we have prepared BSA-loaded FDPLLA par-
ticles and have investigated their morphology and release
kinetics of BSA into water. We have found that the porosity
and speciﬁc surface area of the present FDPLLA are rather
high, which leads to prominent ability of protein loading.
The surface of FDPLLA particle is less porous than the
interior, which is suggested to aﬀect signiﬁcantly the release
rate of BSA. The concentration C0 of the original solution,
from which FDPLLA is prepared, seems to be a key
parameter that controls both BSA loading and release rate: as
C0 decreases, the loading of BSA increases, while the release
rate becomes greater.
The present results suggest that FDPLLA is a promising
material as a carrier for controlled drug release. On the
other hand, it may not be suitable for tissue engineering
applications, because the size of the pore is too small for
cell seeding, growth, and tissue formation. The release rate
observed in this study may be too fast for a practical
use in controlled releasing system. This problem could be
overcome by arranging the surface of the FDPLLA particle
by either chemical or physical treatment. In addition, the
size of the particle could be arranged so as to be suitable for
various medical administrations (ingestion or injection) by
development of spray method on freezing with controlled
viscosity of the solution. We are currently exploring these
techniques.
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